Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure

World Journal of Gastroenterology

Volumn 16, Issue 18, 2010, Pages 2227-2234

  Kantola, Taru ^a   Mäklin, Suvi ^b   Koivusalo, Anna Maria ^a   Räsänen, Pirjo ^b   Rissanen, Anne ^c   Roine, Risto ^c   Sintonen, Harri ^d   Höckerstedt, Krister ^e   Isoniemi, Helena ^e  

^a Surgical Hospital   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Albumin dialysis; Cost efficiency; Healthrelated quality of life; Quality adjusted life year

Indexed keywords

ADOLESCENT; ADULT; AGED; ALBUMIN DIALYSIS; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; FINLAND; HEALTH CARE COST; HUMAN; INTENSIVE CARE UNIT; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952616099     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i18.2227     Document Type: Article

References (34)

1. Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. ASAIO J 1993; 39: M621-M625
2. Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993; 17: 809-813
3. Kantola T, Koivusalo AM, Höckerstedt K, Isoniemi H. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients. Transpl Int 2008; 21: 857-866
4. Lahdenperä A, Koivusalo AM, Vakkuri A, Höckerstedt K, Isoniemi H. Value of albumin dialysis therapy in severe liver insufficiency. Transpl Int 2005; 17: 717-723
5. Kantola T, Koivusalo AM, Parmanen S, Höckerstedt K, Isoniemi H. Survival predictors in patients treated with a molecular adsorbent recirculating system. World J Gastroenterol 2009; 15: 3015-3024
6. Pugliese F, Novelli G, Poli L, Levi Sandri GB, Di Folco G, Ferretti S, Morabito V, Ruberto F, Berloco PB. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients. Transplant Proc 2008; 40: 1925-1928
7. Donati G, Piscaglia F, Colì L, Silvagni E, Righini R, Donati G, Pini P, Stefoni S, Bolondi L. Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. Aliment Pharmacol Ther 2007; 26: 717-726
8. Doria C, Mandalá L, Scott VL, Gruttadauria S, Marino IR. Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a singlecenter experience. Dig Dis Sci 2006; 51: 47-53
9. Koivusalo AM, Teikari T, Höckerstedt K, Isoniemi H. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy. Metab Brain Dis 2008; 23: 387-398
10. El Banayosy A, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R. First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J 2004; 50: 332-337
11. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, Loehr M, Liebe S, Mitzner S, Schmidt R, Stange J. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002; 36: 949-958
12. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Löhr JM, Liebe S, Emmrich J, Korten G, Schmidt R. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277-286
13. Saliba F, Camus C, Durand F, Mathurin P, Delafosse B, Barange K, Belnard M, Letierce A, Ichai P, Samuel D. Randomized controlled multicenter trial evaluating the efficacy and safety of albumin dialysis with MARS in patients with fulminant and subfulminant hepatic failure. The liver meeting 2008, 50th anniversary meeting of the international association for the study of liver. San Francisco 2008. Hepatology 2008; 48: 4 suppl
14. Hessel FP. Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure. Cost Eff Resour Alloc 2006; 4: 16
15. Hessel FP, Mitzner SR, Rief J, Gress S, Guellstorff B, Wasem J. Economic evaluation of MARS--preliminary results on survival and quality of life. Liver 2002; 22 Suppl 2: 26-29
16. Hessel FP, Mitzner SR, Rief J, Guellstorff B, Steiner S, Wasem J. Economic evaluation and 1-year survival analysis of MARS in patients with alcoholic liver disease. Liver Int 2003; 23 Suppl 3: 66-72
17. Talmor D, Shapiro N, Greenberg D, Stone PW, Neumann PJ. When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature. Crit Care Med 2006; 34: 2738-2747
18. Garcia G, Keeffe E. Acute liver failure. In: Friedman LS, Keeffe EB, editors. Handbook of Liver Disease. New York: Churchill Livingstone, 1998: 15-26
19. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001; 33: 328-336
20. Sintonen H. The 15D-measure of health-related quality of life. II. Feasibility, reliability and validity of its valuation system. National Centre for Health Program Evaluation, Working Paper 42, Melbourne, 1995. Available from: URL: http://www.buseco.monash.edu.au/centres/che/pubs/wp42.pdf
21. Sintonen H. The 15D-measure of health-related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system. National Centre for Health Program Evaluation, Working Paper 41, Melbourne, 1994. Available from: URL: http://www.buseco.monash.edu.au/centres/che/pubs/wp41.pdf
22. Sintonen H. The health-related quality of life (HRQoL) instrument. Available from: URL: http://www.15d-instrument.net/15d
23. Stavem K. Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Qual Life Res 1999; 8: 45-54
24. Hawthorne G, Richardson J, Day NA. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med 2001; 33: 358-370
25. Moock J, Kohlmann T. Comparing preference-based qualityof-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Qual Life Res 2008; 17: 485-495
26. Sintonen H. Outcome measurement in acid-related diseases. Pharmacoeconomics 1994; 5 (suppl 3): 17-26
27. Aromaa A, Koskinen S. Health and functional capacity in Finland. baseline results of the health 2000 health examination survey. 2004. Report No.: Publications of National Public Health Institute, Series B 12/2004. Available from: URL: http://www.ktl.fi/attachments/suomi/julkaisut/julkaisusarja_b/2004b12.pdf
28. Tome S, Wells JT, Said A, Lucey MR. Quality of life after liver transplantation. A systematic review. J Hepatol 2008; 48: 567-577
29. Aberg F, Rissanen AM, Sintonen H, Roine RP, Höckerstedt K, Isoniemi H. Health-related quality of life and employment status of liver transplant patients. Liver Transpl 2009; 15: 64-72
30. Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954
31. Khashab M, Tector AJ, Kwo PY. Epidemiology of acute liver failure. Curr Gastroenterol Rep 2007; 9: 66-73
32. Hassanein T, Oliver D, Stange J, Steiner C. Albumin dialysis in cirrhosis with superimposed acute liver injury: possible impact of albumin dialysis on hospitalization costs. Liver Int 2003; 23 Suppl 3: 61-65
33. Räsänen P, Roine E, Sintonen H, Semberg-Konttinen V, Ryynänen OP, Roine R. Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. Int J Technol Assess Health Care 2006; 22: 235-241
34. Epstein AM, Hall JA, Tognetti J, Son LH, Conant L Jr. Using proxies to evaluate quality of life. Can they provide valid information about patients' health status and satisfaction with medical care? Med Care 1989; 27: S91-S98